News – Page 113 – Endpoints News

Hello, neffy: FDA approves first nasal spray for severe allergic reactions

9 months ago

Genentech, Gilead push FDA to modernize research inspections

9 months ago

Alfasigma's PBC treatment Ocaliva to face an FDA adcomm in September

9 months ago

23andMe trades drug discovery for GLP-1 weight loss prescriptions

9 months ago

Autoimmune CAR-Ts are under the microscope after Cabaletta’s safety issue in lupus

9 months ago

Avidity CEO says it's ‘full steam ahead’ in DMD as stock rallies on Phase 1/2 win

9 months ago

A CAR-T deal in China; Zevra’s $60M offering

9 months ago

Novavax plots to reduce European footprint to become a ‘leaner’ company

9 months ago

FDA lifts hold on 4DMT's Fabry gene therapy

9 months ago

Merck pays $700M for clinical-stage CD3xCD19 bispecific antibody

9 months ago

Exclusive: MIT spinout launches with focus on improving DNA payloads for gene insertion

9 months ago

Bill Haney's Dragonfly nabs former Cerevel CFO; Cellectis' new CMO

9 months ago

Infectious disease biotech undergoes makeover after lung disease trial underwhelms

9 months ago

Gilead shells out $320M to J&J to buy out rare liver disease drug royalties

9 months ago

Purdue’s emergency opioid overdose treatment is approved by the FDA

9 months ago

Aldeyra to resubmit dry eye disease drug this year following positive Phase 3 data

9 months ago

Lilly says to ‘take some caution’ on other companies’ early-stage obesity data, calls out compounders

9 months ago

Lilly contributes to isotope supplier fundraise; Layoffs at Ajinomoto

9 months ago

WuXi Bio gains some traction in Europe in the face of Biosecure threat in the US

9 months ago

FDA approves Citius Pharma's non-Hodgkin lymphoma drug Lymphir

9 months ago

Lilly’s anti-tau pill for Alzheimer’s fails in Phase 2 study

9 months ago

Apellis and Sobi land another late-stage win for rare kidney disease drug

9 months ago

Amneal Pharma's extended-release Parkison's treatment clinches FDA approval

9 months ago

Intellia’s gene editing therapy succeeds in Phase 2 genetic swelling condition study

9 months ago

First page Previous page 110 111 112113114 115 116 Next page Last page